The most positive thing right now is they are selling in China again, because they actually have some distribution back now. The old stock has cleared out as well. They should be pushing harder on this front as it is more profitable.
USA is costing them alot to achieve the revenues they are getting. Add in the need/costs for FDA approval, marketing, logistics, tariffs etc and it just seems unsustainable for a company that is burning cash.
You say it will be a reaper in a year or two, well how many more capital raises is that?
Ann: Bubs Q4 FY24 Quarterly Activity and Cashflow Statement, page-59
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $107.1M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 12.0¢ | $26.44K | 220.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 58563 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 1974321 | 29 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| BUB (ASX) Chart |